Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome
To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS). This is a retrospective cohort study, conducted through a telephone survey and chart review. Minimally invasive gynecologic...
Gespeichert in:
| Veröffentlicht in: | Journal of minimally invasive gynecology 2023-03, Vol.30 (3), p.192-198 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 198 |
|---|---|
| container_issue | 3 |
| container_start_page | 192 |
| container_title | Journal of minimally invasive gynecology |
| container_volume | 30 |
| creator | Tavcar, Jovana Movilla, Peter Carusi, Daniela A. Loring, Megan Reddy, Himabindu Isaacson, Keith Morris, Stephanie N. |
| description | To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS).
This is a retrospective cohort study, conducted through a telephone survey and chart review.
Minimally invasive gynecologic surgery center in an academic community hospital.
Database of 355 patients hysteroscopically treated for AS over 4 years. We identified patients who achieved pregnancy past the first trimester and evaluated the incidence and predictors for PAS as well as associated clinical implications.
Telephone survey.
We identified 97 patients meeting the inclusion criteria. Among these patients, 23 (23.7%) patients had PAS. History of cesarean delivery was the only variable statistically significantly associated with having PAS (adjusted odds ratio 4.03, 95% confidence interval 1.31–12.39). PAS was diagnosed antenatally in 3 patients (14.3%), with patients having placenta previa more likely to be diagnosed (p |
| doi_str_mv | 10.1016/j.jmig.2022.11.013 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2742659353</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1553465022010068</els_id><sourcerecordid>2742659353</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-dd14d9b465a995b0ef346599e68e2b60ceea9f02ea4b83de315cf269de5f37fc3</originalsourceid><addsrcrecordid>eNp9kMtKAzEUhoMoWi8v4EKydNMxl0nqgJtSvBQKCuo6ZJITTZlkajIV-vamtLp0df7Fd37O-RC6pKSihMqbZbUM_qNihLGK0opQfoBGVAg-rqVsDv-yICfoNOclIXxCiDxGJ1zWNZsINkJuHo23EA1gHS2edT56ozs8D6uuhMH3MePe4ZdOG4iDxlNjEpT5ugIzpHXA2g2Q8FsCPYRCYNcnPM2fkIKO-HUTbeoDnKMjp7sMF_t5ht4f7t9mT-PF8-N8Nl2MDRdyGFtLa9u05WTdNKIl4HjJTQPyFlgriQHQjSMMdN3ecgucCuOYbCwIxyfO8DN0vetdpf5rDXlQwWcDXacj9Ous2KRmpZALXlC2Q03qc07g1Cr5oNNGUaK2ftVSbf2qrV9FqSp-y9LVvn_dBrB_K79CC3C3A6B8-e0hqWz8Vq_1qQhTtvf_9f8AbRCNWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2742659353</pqid></control><display><type>article</type><title>Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tavcar, Jovana ; Movilla, Peter ; Carusi, Daniela A. ; Loring, Megan ; Reddy, Himabindu ; Isaacson, Keith ; Morris, Stephanie N.</creator><creatorcontrib>Tavcar, Jovana ; Movilla, Peter ; Carusi, Daniela A. ; Loring, Megan ; Reddy, Himabindu ; Isaacson, Keith ; Morris, Stephanie N.</creatorcontrib><description>To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS).
This is a retrospective cohort study, conducted through a telephone survey and chart review.
Minimally invasive gynecologic surgery center in an academic community hospital.
Database of 355 patients hysteroscopically treated for AS over 4 years. We identified patients who achieved pregnancy past the first trimester and evaluated the incidence and predictors for PAS as well as associated clinical implications.
Telephone survey.
We identified 97 patients meeting the inclusion criteria. Among these patients, 23 (23.7%) patients had PAS. History of cesarean delivery was the only variable statistically significantly associated with having PAS (adjusted odds ratio 4.03, 95% confidence interval 1.31–12.39). PAS was diagnosed antenatally in 3 patients (14.3%), with patients having placenta previa more likely to be diagnosed (p <.01). Nine patients (39.13%) with PAS required cesarean hysterectomy, which is 9.3% of those with a pregnancy that progressed past the first trimester. Factors associated with cesarean hysterectomy were the etiology of AS (dilation and evacuation after the second trimester pregnancy or postpartum instrumentation, p <.01), invasive placenta (increta or percreta, p <.05), and history of morbidly adherent placenta in previous pregnancies (p <.05). Two patients with PAS (9.5%) had uterine rupture, and another 2 (9.5%) experienced uterine inversion.
There is a high incidence of PAS and associated morbidity in pregnancies after hysteroscopic treatment for AS. There is a low rate of antenatal diagnosis as well as a lack of reliable clinical predictors, which both stress the importance of clinical awareness, careful counseling, and delivery planning.</description><identifier>ISSN: 1553-4650</identifier><identifier>EISSN: 1553-4669</identifier><identifier>DOI: 10.1016/j.jmig.2022.11.013</identifier><identifier>PMID: 36442752</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Abnormal placentation ; Female ; Gynatresia - epidemiology ; Gynatresia - etiology ; Gynatresia - surgery ; Humans ; Hysterectomy - adverse effects ; Hysteroscopy ; Incidence ; Intrauterine adhesions ; Placenta Accreta - epidemiology ; Placenta Accreta - etiology ; Placenta Accreta - surgery ; Placenta Previa - epidemiology ; Placenta Previa - surgery ; Pregnancy ; Retrospective Studies</subject><ispartof>Journal of minimally invasive gynecology, 2023-03, Vol.30 (3), p.192-198</ispartof><rights>2022 AAGL</rights><rights>Copyright © 2022 AAGL. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-dd14d9b465a995b0ef346599e68e2b60ceea9f02ea4b83de315cf269de5f37fc3</citedby><cites>FETCH-LOGICAL-c356t-dd14d9b465a995b0ef346599e68e2b60ceea9f02ea4b83de315cf269de5f37fc3</cites><orcidid>0000-0001-5635-4404</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1553465022010068$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36442752$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tavcar, Jovana</creatorcontrib><creatorcontrib>Movilla, Peter</creatorcontrib><creatorcontrib>Carusi, Daniela A.</creatorcontrib><creatorcontrib>Loring, Megan</creatorcontrib><creatorcontrib>Reddy, Himabindu</creatorcontrib><creatorcontrib>Isaacson, Keith</creatorcontrib><creatorcontrib>Morris, Stephanie N.</creatorcontrib><title>Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome</title><title>Journal of minimally invasive gynecology</title><addtitle>J Minim Invasive Gynecol</addtitle><description>To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS).
This is a retrospective cohort study, conducted through a telephone survey and chart review.
Minimally invasive gynecologic surgery center in an academic community hospital.
Database of 355 patients hysteroscopically treated for AS over 4 years. We identified patients who achieved pregnancy past the first trimester and evaluated the incidence and predictors for PAS as well as associated clinical implications.
Telephone survey.
We identified 97 patients meeting the inclusion criteria. Among these patients, 23 (23.7%) patients had PAS. History of cesarean delivery was the only variable statistically significantly associated with having PAS (adjusted odds ratio 4.03, 95% confidence interval 1.31–12.39). PAS was diagnosed antenatally in 3 patients (14.3%), with patients having placenta previa more likely to be diagnosed (p <.01). Nine patients (39.13%) with PAS required cesarean hysterectomy, which is 9.3% of those with a pregnancy that progressed past the first trimester. Factors associated with cesarean hysterectomy were the etiology of AS (dilation and evacuation after the second trimester pregnancy or postpartum instrumentation, p <.01), invasive placenta (increta or percreta, p <.05), and history of morbidly adherent placenta in previous pregnancies (p <.05). Two patients with PAS (9.5%) had uterine rupture, and another 2 (9.5%) experienced uterine inversion.
There is a high incidence of PAS and associated morbidity in pregnancies after hysteroscopic treatment for AS. There is a low rate of antenatal diagnosis as well as a lack of reliable clinical predictors, which both stress the importance of clinical awareness, careful counseling, and delivery planning.</description><subject>Abnormal placentation</subject><subject>Female</subject><subject>Gynatresia - epidemiology</subject><subject>Gynatresia - etiology</subject><subject>Gynatresia - surgery</subject><subject>Humans</subject><subject>Hysterectomy - adverse effects</subject><subject>Hysteroscopy</subject><subject>Incidence</subject><subject>Intrauterine adhesions</subject><subject>Placenta Accreta - epidemiology</subject><subject>Placenta Accreta - etiology</subject><subject>Placenta Accreta - surgery</subject><subject>Placenta Previa - epidemiology</subject><subject>Placenta Previa - surgery</subject><subject>Pregnancy</subject><subject>Retrospective Studies</subject><issn>1553-4650</issn><issn>1553-4669</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtKAzEUhoMoWi8v4EKydNMxl0nqgJtSvBQKCuo6ZJITTZlkajIV-vamtLp0df7Fd37O-RC6pKSihMqbZbUM_qNihLGK0opQfoBGVAg-rqVsDv-yICfoNOclIXxCiDxGJ1zWNZsINkJuHo23EA1gHS2edT56ozs8D6uuhMH3MePe4ZdOG4iDxlNjEpT5ugIzpHXA2g2Q8FsCPYRCYNcnPM2fkIKO-HUTbeoDnKMjp7sMF_t5ht4f7t9mT-PF8-N8Nl2MDRdyGFtLa9u05WTdNKIl4HjJTQPyFlgriQHQjSMMdN3ecgucCuOYbCwIxyfO8DN0vetdpf5rDXlQwWcDXacj9Ous2KRmpZALXlC2Q03qc07g1Cr5oNNGUaK2ftVSbf2qrV9FqSp-y9LVvn_dBrB_K79CC3C3A6B8-e0hqWz8Vq_1qQhTtvf_9f8AbRCNWg</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Tavcar, Jovana</creator><creator>Movilla, Peter</creator><creator>Carusi, Daniela A.</creator><creator>Loring, Megan</creator><creator>Reddy, Himabindu</creator><creator>Isaacson, Keith</creator><creator>Morris, Stephanie N.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5635-4404</orcidid></search><sort><creationdate>202303</creationdate><title>Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome</title><author>Tavcar, Jovana ; Movilla, Peter ; Carusi, Daniela A. ; Loring, Megan ; Reddy, Himabindu ; Isaacson, Keith ; Morris, Stephanie N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-dd14d9b465a995b0ef346599e68e2b60ceea9f02ea4b83de315cf269de5f37fc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abnormal placentation</topic><topic>Female</topic><topic>Gynatresia - epidemiology</topic><topic>Gynatresia - etiology</topic><topic>Gynatresia - surgery</topic><topic>Humans</topic><topic>Hysterectomy - adverse effects</topic><topic>Hysteroscopy</topic><topic>Incidence</topic><topic>Intrauterine adhesions</topic><topic>Placenta Accreta - epidemiology</topic><topic>Placenta Accreta - etiology</topic><topic>Placenta Accreta - surgery</topic><topic>Placenta Previa - epidemiology</topic><topic>Placenta Previa - surgery</topic><topic>Pregnancy</topic><topic>Retrospective Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tavcar, Jovana</creatorcontrib><creatorcontrib>Movilla, Peter</creatorcontrib><creatorcontrib>Carusi, Daniela A.</creatorcontrib><creatorcontrib>Loring, Megan</creatorcontrib><creatorcontrib>Reddy, Himabindu</creatorcontrib><creatorcontrib>Isaacson, Keith</creatorcontrib><creatorcontrib>Morris, Stephanie N.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of minimally invasive gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tavcar, Jovana</au><au>Movilla, Peter</au><au>Carusi, Daniela A.</au><au>Loring, Megan</au><au>Reddy, Himabindu</au><au>Isaacson, Keith</au><au>Morris, Stephanie N.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome</atitle><jtitle>Journal of minimally invasive gynecology</jtitle><addtitle>J Minim Invasive Gynecol</addtitle><date>2023-03</date><risdate>2023</risdate><volume>30</volume><issue>3</issue><spage>192</spage><epage>198</epage><pages>192-198</pages><issn>1553-4650</issn><eissn>1553-4669</eissn><abstract>To investigate the incidence, predictors, and clinical implications of placenta accreta spectrum (PAS) in pregnancies after hysteroscopic treatment for Asherman syndrome (AS).
This is a retrospective cohort study, conducted through a telephone survey and chart review.
Minimally invasive gynecologic surgery center in an academic community hospital.
Database of 355 patients hysteroscopically treated for AS over 4 years. We identified patients who achieved pregnancy past the first trimester and evaluated the incidence and predictors for PAS as well as associated clinical implications.
Telephone survey.
We identified 97 patients meeting the inclusion criteria. Among these patients, 23 (23.7%) patients had PAS. History of cesarean delivery was the only variable statistically significantly associated with having PAS (adjusted odds ratio 4.03, 95% confidence interval 1.31–12.39). PAS was diagnosed antenatally in 3 patients (14.3%), with patients having placenta previa more likely to be diagnosed (p <.01). Nine patients (39.13%) with PAS required cesarean hysterectomy, which is 9.3% of those with a pregnancy that progressed past the first trimester. Factors associated with cesarean hysterectomy were the etiology of AS (dilation and evacuation after the second trimester pregnancy or postpartum instrumentation, p <.01), invasive placenta (increta or percreta, p <.05), and history of morbidly adherent placenta in previous pregnancies (p <.05). Two patients with PAS (9.5%) had uterine rupture, and another 2 (9.5%) experienced uterine inversion.
There is a high incidence of PAS and associated morbidity in pregnancies after hysteroscopic treatment for AS. There is a low rate of antenatal diagnosis as well as a lack of reliable clinical predictors, which both stress the importance of clinical awareness, careful counseling, and delivery planning.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36442752</pmid><doi>10.1016/j.jmig.2022.11.013</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-5635-4404</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1553-4650 |
| ispartof | Journal of minimally invasive gynecology, 2023-03, Vol.30 (3), p.192-198 |
| issn | 1553-4650 1553-4669 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2742659353 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Abnormal placentation Female Gynatresia - epidemiology Gynatresia - etiology Gynatresia - surgery Humans Hysterectomy - adverse effects Hysteroscopy Incidence Intrauterine adhesions Placenta Accreta - epidemiology Placenta Accreta - etiology Placenta Accreta - surgery Placenta Previa - epidemiology Placenta Previa - surgery Pregnancy Retrospective Studies |
| title | Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T04%3A57%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence%20and%20Clinical%20Implications%20of%20Placenta%20Accreta%20Spectrum%20after%20Treatment%20for%20Asherman%20Syndrome&rft.jtitle=Journal%20of%20minimally%20invasive%20gynecology&rft.au=Tavcar,%20Jovana&rft.date=2023-03&rft.volume=30&rft.issue=3&rft.spage=192&rft.epage=198&rft.pages=192-198&rft.issn=1553-4650&rft.eissn=1553-4669&rft_id=info:doi/10.1016/j.jmig.2022.11.013&rft_dat=%3Cproquest_cross%3E2742659353%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2742659353&rft_id=info:pmid/36442752&rft_els_id=S1553465022010068&rfr_iscdi=true |